The prevalence of chlamydia trachomatis among patients with acute conjunctivitis in Kasr Alainy ophthalmology clinic.
Bottom Line:
A full history was taken from patients followed by examination of both eyes.The anti-chlamydial antibodies were positive in the tears of 31.1% of patients.While the other bacterial organisms responsible for 14.6%.
View Article:
PubMed Central - PubMed
Affiliation: Family Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
ABSTRACT
Show MeSH
Introduction: Trachoma is a leading cause of avoidable blindness and endemic conjunctivitis in 57 countries. It infects approximately 84 million people globally, and continues to threaten over 10% of the world's population with the risk of blindness. Methods: This is a cross sectional descriptive study assessing patients presenting with acute conjunctivitis. A full history was taken from patients followed by examination of both eyes. A conjunctival swab was taken and a sample of tears was collected and handled at the central laboratory unit at Kasr AlAiny hospital for culture and sensitivity of the swab and ELISA for tears searching for Immunoglobulin G and Immunoglobulin M of chlamydia trachomatis. Results: The prevalence of bacterial conjunctivitis encounted for 45.7% and non-bacterial 54.3% of the studied group. The anti-chlamydial antibodies were positive in the tears of 31.1% of patients. While the other bacterial organisms responsible for 14.6%. Conclusion: The study concluded that trachoma accounts for one third of the cases of acute conjunctivitis while the other bacterial organisms responsible for about 14.6%. More than half of the cases have other causes as viral, allergic, mechanical or chemical induced conjunctivitis. Related in: MedlinePlus |
![]() Related In:
Results -
Collection
License getmorefigures.php?uid=PMC4219799&req=5
Figure 0001: Prevalence of bacterial conjunctivitis among the studied group Mentions: The study results showed that bacterial conjunctivitis encounter 45.7% and non-bacterial encounter 54.3% of our studied group (Figure 1). The bacterial infection is divided 31.1% chlamydia trachomatis and 14.6% other bacterial organisms. The mean age of the studied group was 44.4 ±14.2 standard deviation. The maximum age was 80 years while the minimum was 14 years. Around three-quarters of the study sample were females representing 77.2% of the study sample, while males were 22.8%. Illiterates encounter 65.2% of the study sample, while a total of 76.8% of the sample were not working. Regarding the residency around half of the sample 46.7% lives in urban and half 53.3% live in rural areas. The average income was less than 500 pounds in 64.9% and more than 500 pounds with 35.1%. |
View Article: PubMed Central - PubMed
Affiliation: Family Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Introduction: Trachoma is a leading cause of avoidable blindness and endemic conjunctivitis in 57 countries. It infects approximately 84 million people globally, and continues to threaten over 10% of the world's population with the risk of blindness.
Methods: This is a cross sectional descriptive study assessing patients presenting with acute conjunctivitis. A full history was taken from patients followed by examination of both eyes. A conjunctival swab was taken and a sample of tears was collected and handled at the central laboratory unit at Kasr AlAiny hospital for culture and sensitivity of the swab and ELISA for tears searching for Immunoglobulin G and Immunoglobulin M of chlamydia trachomatis.
Results: The prevalence of bacterial conjunctivitis encounted for 45.7% and non-bacterial 54.3% of the studied group. The anti-chlamydial antibodies were positive in the tears of 31.1% of patients. While the other bacterial organisms responsible for 14.6%.
Conclusion: The study concluded that trachoma accounts for one third of the cases of acute conjunctivitis while the other bacterial organisms responsible for about 14.6%. More than half of the cases have other causes as viral, allergic, mechanical or chemical induced conjunctivitis.